Israel-based Teva Pharmaceuticals has denied orchestrating a billion-dollar price-fixing scheme with 19 other generic drug manufacturers, after 44 US states filed a lawsuit alleging malpractice. “The allegations in this new complaint, and in the litigation more generally, are just that – allegations,” Teva officials wrote in a statement. The missive added that the company will “review the issue internally and has not engaged in any conduct that would lead to civil or criminal liability.” The 500-page lawsuit, filed by Connecticut Attorney General William Tong, claims the Israeli pharmaceutical company conspired with competitors to raise prices – in some cases by up to 1,000 percent – on 112 different generic drugs between July 2013 and January 2015. The plaintiffs are seeking unspecified damages and urged the court to take action to restore competition in the market.
This holiday season, give to:
Truth and understanding
The Media Line's intrepid correspondents are in Israel, Gaza, Lebanon, Syria and Pakistan providing first-person reporting.
They all said they cover it.
We see it.
We report with just one agenda: the truth.
